Original Article

You have full text access to this OnlineOpen article

Depression as a predictor of disease progression and mortality in cancer patients†

A Meta-Analysis

  1. Jillian R. Satin MA‡,*,
  2. Wolfgang Linden PhD,
  3. Melanie J. Phillips BSc

Article first published online: 14 SEP 2009

DOI: 10.1002/cncr.24561

Issue

Cancer

Cancer

Volume 115, Issue 22, pages 5349–5361, 15 November 2009

Additional Information

How to Cite

Satin, J. R., Linden, W. and Phillips, M. J. (2009), Depression as a predictor of disease progression and mortality in cancer patients. Cancer, 115: 5349–5361. doi: 10.1002/cncr.24561

Author Information

  1. Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada

  1. ‡

    Fax: (604) 822-6923

*Department of Psychology, University of British Columbia, 2136 West Mall, Vancouver, British Columbia, V6T 1Z4 Canada

  1. †

    We thank Paul Ruescher and Alena Talbot Ellis for their help with data collection. We extend our appreciation to Drs Gregory Miller, Liisa Galea, Carolyn Gotay, and Andrea Vodermaier for reviewing earlier drafts of this manuscript.

Publication History

  1. Issue published online: 3 NOV 2009
  2. Article first published online: 14 SEP 2009
  3. Manuscript Accepted: 21 APR 2009
  4. Manuscript Revised: 16 MAR 2009
  5. Manuscript Received: 7 NOV 2008

Funded by

  • Michael Smith Foundation for Health Research
  • New Investigator Team grant, Canadian Institutes for Health Research. Grant Number: #AQC83559

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (454K)

References

  • 1
    Levin T, Kissane DW. Psychooncology: the state of its development in 2006. Eur J Psychiat. 2006; 20: 183-197.
  • 2
    Lemon J, Edelman S, Kidman AD. Perceptions of the “Mind-Cancer” relationship by members of the public, cancer patients and oncologists. J Psychosoc Oncol. 2004; 21: 43-58.
  • 3
    van't Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med. 1996; 59: 280-293.
  • 4
    Thaker PM, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Med. 2006; 12: 939-944.
  • 5
    Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999; 80: 880-888.
    Direct Link:
  • 6
    Palermo-Neto J, de Oliviera Massoco C, Robespierre de Souza W. Effects of physical and psychological stressors on behavior, macrophage activity, and Ehrlich tumor growth. Brain Behav Immun. 2003; 17: 43-54.
  • 7
    Saul AN, Oberyszyn TM, Daugherty C, et al. Chronic stress and susceptibility to skin cancer. J Natl Cancer Instit. 2005; 97: 1760-1767.
  • 8
    Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004; 5: 617-625.
  • 9
    Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008; 8: 887-899.
  • 10
    Shekelle RB, Raynor WJ Jr, Ostfeld AM. Psychological depression and 17-year risk of death from cancer. Psychosom Med. 1981; 43: 117-125.
  • 11
    Zonderman AB, Costa P Jr, McCrae RR. Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA. 1989; 262: 1191-1195.
  • 12
    Kaplan GA, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study. J Behav Med. 1988; 11: 1-13.
  • 13
    Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989; 2: 888-891.
  • 14
    Edelman S, Lemon J, Bell DR, et al. Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology. 1999; 8: 474-481.
    Direct Link:
  • 15
    Edmonds CV, Lockwood GA, Cunningham AJ. Psychological response to long-term therapy: a randomized trial with metastatic breast cancer patients. Psychooncology. 1999; 8: 74-91.
    Direct Link:
  • 16
    Cunningham AJ, Edmonds CV, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology. 1998; 7: 508-517.
  • 17
    Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345: 1719-1726.
  • 18
    Kissane DW, Love A, Hatton A, et al. The effect of cognitive-existential group therapy on survival in early stage breast cancer. J Clin Oncol. 2004; 2: 4255-4260.
  • 19
    Coyne JC, Stefanek M, Palmer SC. Psychotherapy and survival in cancer: the conflict between hope and evidence. Psych Bull. 2007; 133: 367-394.
  • 20
    Chow E, Tsao MN, Harth T. Does psychosocial intervention improve survival in cancer? A meta-analysis. Palliat Med. 2004; 18: 25-31.
  • 21
    Edwards AG, Hailey S, Maxwell M. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2004; 2: CD004253.
  • 22
    Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psych. 1995; 14: 101-108.
  • 23
    Smedslund G, Ringdal GI. Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients. J Psychosom Res. 2004; 57: 123-131.
  • 24
    Milo KM. The relationship between depression and cancer survival. Med Health. 2003; 86: 249-250.
  • 25
    Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psych. 2003; 54: 269-282.
  • 26
    De Boer MF, Ryckman RM, Pruyn JF, Van den Borne HW. Psychosocial correlates of cancer relapse and survival: a literature review. Patient Educ Couns. 1999; 37: 215-230.
  • 27
    Reich M. Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol. 2008; 20: 353-359.
  • 28
    Hilakivi-Clarke L, Rowland J, Clarke R, Lippman ME. Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res Treat. 1994; 29: 141-160.
  • 29
    McGee R, Williams S, Elwood M. Depression and the development of cancer: a meta-analysis. Soc Sci Med. 1994; 38: 187-192.
  • 30
    Andrykowski MA, Brady MJ, Henslee-Downey PJ. Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med. 1994; 56: 432-439.
  • 31
    Barraclough J, Pinder P, Cruddas M, Osmond C, Taylor I, Perry M. Life events and breast cancer prognosis. BMJ. 1992; 304: 1078-1081.
  • 32
    Beresford TP, Alfers J, Mangum L, Clapp L, Martin B. Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms. Psychosomatics. 2006; 47: 247-253.
  • 33
    Bergenmar M, Nilsso B, Hansson J, Brandberg Y. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol. 2004; 43: 161-168.
  • 34
    Broers S, Hengeveld MW, Kaptein AA, Le Cessie S, van de Loo F, de Vries T. Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. Journal Psychosom Res. 1998; 45: 341-351.
  • 35
    Brown KW, Levy AR, Rosberger Z, Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med. 2003; 65: 636-643.
  • 36
    Buccheri G. Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J. 1998; 11: 173-178.
  • 37
    Chang G, Orav EJ, McNamara T, Tong M-Y, Antin JH. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer. 2004; 101: 782-789.
    Direct Link:
  • 38
    Faller H, Schmidt M. Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology. 2004; 13: 359-363.
    Direct Link:
  • 39
    Graham J, Ramirez A, Love S, et al. Stressful life experiences and risk of relapse of breast cancer. BMJ. 2002; 324: 1420.
  • 40
    Gripp S, Moeller S, Bolke E, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007; 25: 3313-3320.
  • 41
    Groenvold M, Peterson MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007; 105: 209-219.
  • 42
    Grulke N, Larbig W, Kachele H, Bailer H. Pre-transplant depression as risk factor for survival of patients undergoing allogenic haematopoietic stem cell transplantation. Psychooncology. 2008; 17: 480-487.
    Direct Link:
  • 43
    Lam PT, Leung MW, Tse CY. Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J. 2007; 13: 453-459.
  • 44
    Lehto US, Ojanen M, Dyba T, et al. Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res. 2007; 63: 9-15.
  • 45
    Lloyd-Williams M, Shiels C, Taylor F, Dennis M. Depression – an independent predictor of early death in patients with advanced cancer. J Affect Disord. 2009; 113: 127-132.
  • 46
    Mainio A, Tuunanen S, Hakko H, Niemela A, Kolvukangas J, Rasanen P. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006; 256: 516-521.
  • 47
    Murphy KC, Jenkins PL, Whittaker JA. Psychosocial morbidity and survival in adult bone marrow transplant recipients: a follow-up study. Bone Marrow Transplant. 1996; 18: 199-201.
  • 48
    Nakaya N, Saito-Nakaya K, Akizuki N, et al. Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Sci. 2006; 97: 199-205.
    Direct Link:
  • 49
    Nakaya N, Saito-Nakaya K, Akechi T, et al. Negative psychological aspects and survival in lung cancer patients. Psychooncology. 2008; 17: 466-473.
    Direct Link:
  • 50
    Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006; 28: 396-402.
  • 51
    Osborne RH, Sali A, Aaronson NK, Elsworth GR, Mdzewski B, Sinclair AJ. Immune function and adjustment style: do they predict survival in breast cancer? Psychooncology. 2004; 3: 199-210.
  • 52
    Phillips K-A, Osborne RH, Giles GG, et al. Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study. J Clin Oncol. 2008; 26: 4666-4671.
  • 53
    Pirl WF, Temel JS, Billings A, et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics. 2008; 49: 218-224.
  • 54
    Prieto JM, Atala J, Blanch J, et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol. 2005; 23: 6063-6071.
  • 55
    Richardson JL, Zarnegar Z, Bisno B, Levine A. Psychosocial status at initiation of cancer treatment and survival. J Psychosom Res. 1990; 34: 189-201.
  • 56
    Ringdal GI, Gotestam KG, Kaasa S, Kvinnsland S, Ringdal K. Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer. 1996; 73: 1594-1599.
  • 57
    Saito-Nakaya K, Nakaya N, Akechi T, et al. Marital status and non-small cell lung cancer survival: the lung cancer database project in Japan. Psychooncology. 2008; 17: 869-876.
    Direct Link:
  • 58
    Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007; 25: 2397-2405.
  • 59
    Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer. 2002; 94: 2719-2727.
    Direct Link:
  • 60
    Watson M, Homewood J, Haviland J, Bliss JM. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer. 2005; 41: 1710-1714.
  • 61
    Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta-Analysis. Version 2. Englewood, NJ: Biostat Inc; 2005.
  • 62
    Stroup DF, Berlin JF, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000; 283: 2008-2012.
  • 63
    Borenstein M. A Short Course in Meta-Analysis [e-book]. 2005. Available at: http://www.Meta-Analysis.com Accessed on May 7, 2007.
  • 64
    Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 2: 1539-1558.
    Direct Link:
  • 65
    Barth J, Schumacher M, Hermann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004; 66: 802-813.
  • 66
    de Graeff A, de Leeuw JRJ, Ros WJG, Hordijk GJ, Blijham GH, Winnubst JAM. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer. 2001; 37: 332-339.
  • 67
    Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA. 1979; 242: 1504-1508.
  • 68
    Edwards J, DiClemente G, Samuels ML. Psychological characteristics: a pretreatment survival marker of patients with testicular cancer. Psychosoc Oncol. 1985; 3: 79-94.
  • 69
    Faller H, Bulzebruck H, Drings P, Lang H. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry. 1999; 56: 756-762.
  • 70
    Gilbar O. The connection between the psychological condition of breast cancer patients and survival: a follow-up after 8 years. Gen Hosp Psychiatry. 1996; 18: 266-270.
  • 71
    Jamison RN, Burish TG, Wallston KA. Psychogenic factors in predicting survival of breast cancer patients. J Clin Oncol. 1987; 5: 768-772.
  • 72
    Lehto U-S, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P. Baseline psychosocial predictors of survival in localized breast cancer. Br J Cancer. 2006; 94: 1245-1252.
  • 73
    Leigh H, Percarpio B, Opsahl C, Ungerer J. Psychological predictors of survival in cancer patients undergoing radiation therapy. Psychother Psychosom. 1987; 47: 65-73.
  • 74
    Meyer HAM, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliat Med. 2003; 17: 604-607.
  • 75
    Morris T, Pettingale K, Haybittle J. Psychological response to cancer diagnosis and disease outcome in patients with breast cancer and lymphoma. Psychooncology. 1992; 1: 105-114.
    Direct Link:
  • 76
    Naughton MJ, Herndon JE, Shumaker SA, et al. The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res. 2002; 11: 235-248.
  • 77
    Palmer JL, Fisch MJ. Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage. 2005; 29: 565-571.
  • 78
    Pamuk GE, Harmandar F, Ermantas N, et al. EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression. Ann Hematol. 2008; 87: 305-310.
  • 79
    Schulz R, Bookwala J, Knapp JE, Scheier M, Williamson GM. Pessimism, age, and cancer mortality. Psychol Aging. 1996; 11: 304-309.
  • 80
    Viganó A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000; 160: 861-868.
  • 81
    Aass N, Fossa SD, Dahl AA, Moe TJ. Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital. Eur J Cancer. 1997; 33: 1597-1604.
  • 82
    Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002; 72: 227-236.
  • 83
    Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psych Bull. 2004; 130: 601-630.
  • 84
    Levy SM, Roberts DC. Clinical Significance of Psychoneuroimmunulogy: Prediction of Cancer Outcomes. In: Schneiderman N, McCabe P, Baum A, eds. Perspectives in Behavioral Medicine: Stress and Disease Processes. Hillsdale, NJ: Lawrence Erlbaum Associates; 1992: 165-174.
  • 85
    Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008; 26: 1355-1363.
  • 86
    Linden W, Satin JR. Avoidable pitfalls in behavioural medicine outcome research. Ann Behav Med. 2007; 33: 143-147.
View Full Article (HTML) Get PDF (454K)